First of all, the Court rejects the first potential interpretation, according to which it is enough for the reference medicinal product to have been authorised in the Member State concerned at a given time and there is no need for that authorisation still to be in force on the date when the application for marketing authorisation of the generic medicinal product is lodged.
Προδικαστική «Φάρμακα — Άδεια κυκλοφορίας φαρμάκου κοινόχρηστης ονομασίας — Ανάκληση της άδειας κυκλοφορίας του φαρμάκου αναφοράς — Διαδικασία περιληπτικής αιτήσεως» (Έκτο τμήμα)